J&J does not have large inventory of doses, Biden official says

Johnson & Johnson will not have “a big inventory” of its Covid-19 vaccine ready ahead of its regulatory clearance expected this month, President Joe Biden’s Covid czar said Wednesday.

Jeff Zients said the administration has learned in the last couple of weeks that J&J will have only “a few million” doses manufactured when its single-shot vaccine is likely authorized by the Food and Drug Administration.

Federal and state health officials were expecting vaccine supply to rapidly increase after the emergency use authorization of J&J’s vaccine. The FDA has scheduled a meeting of its Vaccines and Related Biological Products…